Vice President at Nextcea to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11

Frank Hsieh, Vice President at Nextcea to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA

April 24, 2008 (FPRC) -- Dr. Frank Hsieh, Vice President at Nextcea will be speaking at GTCbio’s 2nd Annual Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA. Dr. Hsieh will present on “Biomarkers for Predictive Toxicology.”

The drug discovery and development process has become an increasingly expensive and lengthy process. One approach for cost/time reduction is through development of early in vivo markers of toxic response. The integration of predictive biomarkers with traditional methods for drug safety testing may provide a stronger rationale for selecting compounds to advance into the clinic. Advances in overall protein and metabolic profiling now make it possible to perform simultaneous toxicodynamic (TD) biomarker discovery, toxicokinetic analysis and drug metabolic profiling. The broader potential of biomarker analysis however lies in clinical development and patient care. Biomarkers may be used to identify patient response and establish effective and safe dosage regimens. Biomarkers may also reveal on-target versus off-target response and toxicological outcomes during drug treatment. Examples of these applications will be presented.

The 2nd Annual Rediscovering Biomarkers Conference will expose attendees to the latest advancements and developments in biomarkers and predictive medicine. Attendees will gain insight into discovery and development processes, hear about new biomarkers and upcoming trends in the industry, as well as the status of those in clinical trials. Delegates will also receive highly valuable information on tools for improving reimbursement strategies and the efficacy and validation of biomarkers.

For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/conferenceDetails.aspx?id=124
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com


For more information contact Rania Hafez of GTCbio (http://www.gtcbio.com)
(626) 256-6405

Keywords: biomarkers

You can read this press release online at: http://www.free-press-release-center.info/pr00000000000000014002.html